Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma (Jul, 10.1038/s43018-023-00610-2, 2023)
Renata Varaljai,Lisa Zimmer, Yahya Al-Matary,Paulien Kaptein,Lea J. Albrecht, Batool Shannan,Jan C. Brase,Daniel Gusenleitner,Teresa Amaral,Nina Wyss,Jochen Utikal,Lukas Flatz,Florian Rambow,Hans Christian Reinhardt, Jenny Dick,Daniel R. Engel,Susanne Horn,Selma Ugurel,Wiebke Sondermann,Elisabeth Livingstone,Antje Sucker,Annette Paschen,Fang Zhao,Jan M. Placke,Jasmin M. Klose,Wolfgang P. Fendler,Daniela S. Thommen,Iris Helfrich,Dirk Schadendorf,Alexander Roesch NATURE CANCER（2023）
AI 理解论文
溯源树
样例
